prices
28.06.2017
Substitutability of Hepatitis C drugs, established by FAS, saved more than 18 million RUB to the budgetmore
FAS sent explanations to the Ministry of Health Care of the Russian Federation on preparing documents for procurement of medicinal drugs with the “Cepeginterferon alpha-2b” and “Peginterferon alpha-2b” International Non-Proprietary Names (INN)
more
Head of FAS Department for Control over Social Sphere and Trade, Timophey Nizhegorodtsev reviewed large-scale changes in the pharmaceutical sector in the past ten years
more
The company is suspected of fixing monopolistically high price for “Tyverb” medicinal drug
more
20.04.2017
FAS completed the third stage of an international comparative study of medicinal rug pricesmore
At this stage FAS compared vaccine prices
more
The third stage of comparative analysis of drug prices exposed pricing violations for 7 medicines in Russia
more